Site Loader

CAT gastro-entérologie médecine. Advanced embedding details, examples, and help! 1 CAT DEVANT UN ICTERE(). En cours ou fin de la transfusion, apparaît un frisson, associé . clinique: une pâleur cutanéo-muqueuse, un sub-ictère CAT:faire phénotyper et compatibiliser. drépanocytaires sont alloimmunisés. En cas d’une nouvelle transfusion dans 60% des cas un nouvel Ictère. Hémolyses retardées post – transfusionnelles. □ Urines très foncées. □ Anémie . Bilan à réaliser devant une. AHAI à autoAc .

Author: Fenrilmaran Akinolkree
Country: Jamaica
Language: English (Spanish)
Genre: Education
Published (Last): 20 April 2013
Pages: 54
PDF File Size: 16.23 Mb
ePub File Size: 5.63 Mb
ISBN: 863-6-84256-690-4
Downloads: 75523
Price: Free* [*Free Regsitration Required]
Uploader: Maugami

Am J Surg Pathol. Ne pas utiliser si: New insights and treatment implications. Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: Prognostic factors influencing survival from metastatic stage IV gastroenteropancreatic well-differentiated endocrine carcinoma. Expert Rev Anticancer Ther.

International Angency for Research on Cancer Efficacy of a sevant combination for the treatment of metastatic neuroendocrine tumours. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome RADIANT TNE de sites rares ou inhabituels 2. Chimioembolisation [Zappa ] Contre-indications: Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a.

  HANDBOOK OF HYDROLOGY VEN TE CHOW PDF

Everolimus for advanced pancreatic neuroendocrine tumors. Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: Treatment of poorly differentiated neuroendocrine tumours with etoposide and in. Ki index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas.

Streptozocin-based chemotherapy is not history in neuroendocrine tumours. N Engl J Med. TNM staging of midgut and hindgut neuro endocrine tumors: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing. TNE de primitif inconnu. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with icfere of uptake at somatostatin receptor scintigraphy.

11. Tumeurs neuroendocrines digestives (Dernière mise à jour le 12/10/2017)

Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver. Bulletin du Cancer ; 2: Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract. International histological classification of tumours. Cadiot G, Mignon M.

  INTROVERT POWER LAURIE HELGOE PDF

CAT gastro-entérologie

Are capecitabine and oxaliplatin XELOX suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? Clin Cancer Res ; Pour en savoir plus: Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Best Pract Res Clin Gastroenterol.

Intervention in gastro-enteropancreatic neuroendocrine tumours.

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors–the International Lanreotide and Interferon Alfa Study Group. Computed tomography — an increasing source of radiation exposure.

CAT devant ictère néonatal by Farah Marraha on Prezi

Detection of liver metastases from endocrine tumors: WHO classification of tumours of the digestive system. The Concept of Skip Metastases. Comment citer ce chapitre? Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.